A study to learn if nirogacetat works and is safe for adult participants with desmoid tumors: a plain language summary of the DeFi study

Author Information

Bernd Kasper a, Jeanne Whiting b*, Dana Lawson c, Marlene Portnoy b, Kathrin Schuster d, Christina Baumgarten d, Ravin Ratan a, Allison Lim f*, Sunny Chof *, Shivaani Kummar g & Mrinal Gounder h

aUniversity of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center, Sarcoma Unit, Mannheim, Germany; bThe Desmoid Tumor Research Foundation, USA; cPatient Author; dSarcoma Patient Advocacy Global Network, Diessen am Ammersee, Germany; eThe Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA; fSpringWorks Therapeutics, Inc., Stamford, CT, USA; gThe Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; hSarcoma Medical Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA

Publication

Future Oncology